APA (7th ed.) Citation

Yang, M., Schell, M. J., Salk, J. J., Higgins, J., Hipp, M., Pflieger, L., . . . Yeatman, T. J. (2026). Development of an APC and TP53-based duplex sequencing assay to positively predict colorectal cancer response to anti-EGFR therapy. Cellular Oncology (2211-3428), 49(1), 1. https://doi.org/10.1007/s13402-025-01140-y

Chicago Style (17th ed.) Citation

Yang, Mingli, Michael J. Schell, Jesse J. Salk, Jake Higgins, Michael Hipp, Lance Pflieger, Warren Jack Pledger, and Timothy J. Yeatman. "Development of an APC and TP53-based Duplex Sequencing Assay to Positively Predict Colorectal Cancer Response to Anti-EGFR Therapy." Cellular Oncology (2211-3428) 49, no. 1 (2026): 1. https://doi.org/10.1007/s13402-025-01140-y.

MLA (9th ed.) Citation

Yang, Mingli, et al. "Development of an APC and TP53-based Duplex Sequencing Assay to Positively Predict Colorectal Cancer Response to Anti-EGFR Therapy." Cellular Oncology (2211-3428), vol. 49, no. 1, 2026, p. 1, https://doi.org/10.1007/s13402-025-01140-y.